Search - tctmd.com

Displaying 101 - 120 of 832

Sort: Relevancy | Date

Presentation NY Valves 2024

Cases 3/4 : SAVR at 10 Years and SVD at 2 Years: Echo and Clinical

Presenter: Mark Lebehn

June 06, 2024

Presentation NY Valves 2024

Echo-Derived Gradients Increase at 30 Days in Most Patients After Balloon-Expandable TAVR Irrespective of Valve Type and Valve Size

Presenter: Spencer Ng

June 06, 2024

Presentation NY Valves 2024

Invasive Versus Echocardiographic Transvalvular Pressure Gradients After Transcatheter Aortic Valve Implantation

Presenter: Eishan Ashwat

June 06, 2024

Presentation NY Valves 2024

Echocardiographic Characterization

Presenter: Rebecca T. Hahn

June 05, 2024

Presentation NY Valves 2024

Patient-Specific Assessment of Mitral Valve Remodeling Following TEER Using Transesophageal Echocardiography

Presenter: Natalie Simonian

June 05, 2024

Presentation NY Valves 2024

Screening for Transcatheter Native Tricuspid Intervention: Echocardiography

Presenter: Anna Sannino

June 05, 2024

Presentation NY Valves 2024

Screening for Transcatheter Native Mitral Valve Intervention: Echocardiography

Presenter: Akhil Narang

June 05, 2024

News Conference News NY Valves 2024

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Michael O'Riordan

June 05, 2024

Presentation NY Valves 2024

An Automated Echocardiogram Screening Program to Optimize Treatment of Mitral Regurgitation: A Single Center Experience

Presenter: Bharat Ravishankar

June 05, 2024

Presentation NY Valves 2024

Current and Future use of Artificial Intelligence in Echocardiography

Presenter: Akhil Narang

June 05, 2024

Presentation NY Valves 2024

Echocardiographic Speckle Strain Imaging and Valvular Heart Disease Outcomes

Presenter: Madalina Garbi

June 05, 2024

Presentation NY Valves 2024

Risk Stratification for Aortic Regurgitation: Echo or CMR?

Presenter: Joao L. Cavalcante

June 05, 2024

Presentation NY Valves 2024

Assessing Severity of Mixed Valve Disease Based on Multi-Modality Imaging and Echo Hemodynamics

Presenter: Anjali Sharma

June 05, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Conference News ESOC 2024

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

Todd Neale

May 17, 2024

Presentation EuroPCR 2024

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Presenter: Patrick Serruys

May 15, 2024

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

Presentation EuroPCR 2024

Short Methodology Insight - LANDMARK

Presenter: Davide Capodanno

May 14, 2024

News Conference News

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

Yael L. Maxwell

May 06, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

Advertisement

Cases 3/4 : SAVR at 10 Years and SVD at 2 Years: Echo and Clinical

Echo-Derived Gradients Increase at 30 Days in Most Patients After Balloon-Expandable TAVR Irrespective of Valve Type and Valve Size

Invasive Versus Echocardiographic Transvalvular Pressure Gradients After Transcatheter Aortic Valve Implantation

Echocardiographic Characterization

Patient-Specific Assessment of Mitral Valve Remodeling Following TEER Using Transesophageal Echocardiography

Screening for Transcatheter Native Tricuspid Intervention: Echocardiography

Screening for Transcatheter Native Mitral Valve Intervention: Echocardiography

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

An Automated Echocardiogram Screening Program to Optimize Treatment of Mitral Regurgitation: A Single Center Experience

Current and Future use of Artificial Intelligence in Echocardiography

Echocardiographic Speckle Strain Imaging and Valvular Heart Disease Outcomes

Risk Stratification for Aortic Regurgitation: Echo or CMR?

Assessing Severity of Mixed Valve Disease Based on Multi-Modality Imaging and Echo Hemodynamics

June 2024 Dispatch for the CV Team

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Short Methodology Insight - LANDMARK

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content